shutterstock_255876943_drug discovery d3

ISNTD d3 2022
Drug discovery, development & diagnostics
for neglected tropical diseases

Online conference 

29-30th June 2022

#ISNTDd3

#beatNTDs

Introduction

ISNTD d³ 2022 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities. 

This year, against the backdrop of the recently launched WHO NTD Roadmap and the shock of the COVID19 pandemic, ISNTD d³ will focus on the shifts, gaps and future needs of drug discovery, treatments and diagnostics in context of global health as well as broader challenges.

Presentations & panel discussions will run on both days, and partnership meetings can be arranged throughout the day.

Please contact krafiq@isntd.org for further details including speaking & attending and to become a conference sponsor.

Programme

Register here 

Thanks for submitting! Your registration has been successful.

DRUG DISCOVERY & DEVELOPMENT

ISNTD d3 2022: DAY 1

29 JUNE 2022

11.00-12.15 UTC

Pipeline, access and financing: challenges in new discovery in NTDs

Developing interventions for developing countries 

Prof Kishor Wasan (Adjunct Professor & Distinguished University Scholar, Co-Director & Co-Founder, Neglected Global Diseases Initiative, University of British Columbia) 

Acrylonitrile derivatives against Leishmania amazonensis: towards new treatments in NTDs

Dr Atteneri López-Arencibia (Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Tenerife, Islas Canarias, Spain)

Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel

Dr Jonathan S. Marchant (Marcus Professor & Chair, Medical College of Wisconsin)

Mobilizing private capital to catalyze health innovation and in LMICs and help achieve NTDs Goals

Dr Carolina Batista (Head of Global Health Affairs, Baraka Impact Finance; Barcelona Institute for Global Health and International Board Member Médecins Sans Frontières and DNDi Access Committee)

Isaac T. Chikwanha (Senior Director, Investment Strategy, Access & Delivery, Global Health Innovative Technology GHIT)

12.30-13.45 UTC

Innovation in data collaborations for future NTD treatments

Dr Marco Schito (Executive Director, C-Path CURE Drug Repurposing Collaboratory, CDRC, USA)

IDDO's clinical data-sharing platform and the future of NTD treatments

Dr Martin Walker (Infectious Diseases Data Observatory, IDDO)

Ivermectin for malaria

Joanna Furnival Adams (Broad One Health Endectocide-based Malaria Intervention in Africa, BOHEMIA, IS Global, Spain)

14.00-16.00 UTC

Disease focus: sleeping sickness, de-risking discovery through partnerships and driving sustainability through access   

Philippe Neau (Head of Neglected Tropical Diseases Program at Sanofi Global Health)

Florent Mbo  Access Leader and Regional HATplatform Coordinator

Drugs for Neglected Diseases initiative (DNDi), RDC 


François Bompart (Access Committee Chair, DNDi)

DIAGNOSTICS FOR NEGLECTED TROPICAL DISEASES

ISNTD d3 2022: DAY 2

30 JUNE 2022

8.30-10.00 UTC

NTD diagnostics & the future of disease elimination

Dr Sarah Nogaro (FIND, the global alliance for diagnostics)

Dr Aubrey Cunnington (Digital Diagnostics for Africa & Imperial College London)

Dr Bruno Levecke (Department of Translational Physiology, Infectiology and Public Health, Ghent Univeristy)

10.15-11.45 UTC

Novel point-of-care diagnostics 

Digital optical diagnostics for schistosomiasis and the Schistoscope

Dr. Temitope Agbana (Post-Doc, Delft University of Technology TU Delft and INSPiRED project)

Cygnus smartphone multiplex microcapillary diagnostics for rapid serotype-specific NS1 detection of dengue

Dr Alexander Edwards (Reading School of Pharmacy, University of Reading UK)

 

A handheld quantitative G6PD diagnostic tool to improve point-of-care malaria diagnosis

Dr Benedikt Ley (Senior Research Fellow, Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Australia)

‘The highs and lows on the road to developing an RDT for the non-invasive, point-of-care diagnosis of schistosomiasis’

Elias Kabbas-Pinango  (PhD Candidate, Lamberton Lab, Uni of Glasgow)

12.15-13.45 UTC

Molecular-based approaches for NTDs diagnostics

Multiplex real-time qPCR assay for leprosy diagnosis

Dr Alexandre Dias Tavares Costa (Instituto de Biologia Molecular do Paraná, FIOCRUZ, Curitiba, Brazil, Laboratório de Ciências e Tecnologias Aplicadas à Saúde (LaCTAS), Instituto Carlos Chagas, Fundação Oswaldo Cruz/FIOCRUZ)

“Mail order” RNA-sequencing of single tapeworm egg isolates from stool samples for the diagnosis of Taenia solium infections 

Henrik Sadlowski (Charité-Universitätsmedizin Berlin; NeuroCure NCRC) 

Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers

Dr Javier Sotillo (Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Australia and Instituto de Salud Carlos III, Spain)

Novel molecular methods for Lab-on-Chip diagnostics systems

Dr Kenny Malpartida-Cardenas (Department of Electrical and Electronic Engineering, Imperial College London)

14.15-15.45 UTC

Capacity building in NTDs diagnostics

Malaria microscopy education programme 

Dr Jim Mulry (Merck Global Health Institute)

Strengthening veterinary diagnostic capacities: the FAO Laboratory Mapping Tool

Dr Morgane Gourlaouen (EMPRES Laboratory Unit, Animal Health Services NSAH, Food and Agriculture Organization of the United Nations FAO, Italy)